Vikas Fotedar Selected Research

gadoversetamide (OptiMARK)

1/2018

DCE-MRI and parametric imaging in monitoring response to neoadjuvant chemotherapy in breast carcinoma: a preliminary report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vikas Fotedar Research Topics

Disease

1	Carcinoma (Carcinomatosis) 07/2021
1	Rectal Neoplasms (Rectal Cancer) 06/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2019
1	Neoplasms (Cancer) 10/2019
1	Body Weight (Weight, Body) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2014
1	Periodontal Diseases (Periodontal Disease) 09/2014
1	Dental Caries (Decay, Dental) 09/2014

Drug/Important Bio-Agent (IBA)

1	gadoversetamide (OptiMARK)FDA Link 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 10/2014
1	cyclopropapyrroloindoleIBA 09/2014

Therapy/Procedure

2	Neoadjuvant Therapy 06/2020 - 01/2018
1	Chemoradiotherapy 07/2021
1	Consolidation Chemotherapy 06/2020
1	Drug Therapy (Chemotherapy) 06/2020
1	Radiotherapy 06/2020
1	Brachytherapy 10/2019
1	Dental Care 09/2014